|
|
|
Insider
Information: |
Ciechanover Isaac E. |
Relationship: |
Chief Executive Office... |
City: |
Brisbane |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
332,243 |
|
Indirect Shares
|
290,687 |
|
|
Direct
Value |
$230,344 |
|
|
Indirect Value
|
$201,533 |
|
|
Total
Shares |
622,930 |
|
|
Total
Value |
$431,877 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2016-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
555,044 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2016-11-22 |
4 |
AS |
$18.21 |
$152,964 |
I/I |
(8,400) |
388,578 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2016-11-23 |
4 |
AS |
$18.40 |
$67,142 |
I/I |
(3,600) |
384,978 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2016-12-06 |
4 |
AS |
$18.55 |
$66,780 |
I/I |
(3,600) |
381,378 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2016-12-07 |
4 |
AS |
$17.30 |
$62,280 |
I/I |
(3,600) |
377,778 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2016-12-22 |
4 |
AS |
$15.17 |
$36,473 |
I/I |
(2,400) |
375,378 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2016-12-23 |
4 |
AS |
$15.25 |
$36,600 |
I/I |
(2,400) |
372,978 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-02-02 |
4 |
AS |
$13.45 |
$32,280 |
I/I |
(2,400) |
356,178 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-02-03 |
4 |
AS |
$13.87 |
$33,288 |
I/I |
(2,400) |
353,778 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-02-15 |
4 |
AS |
$15.54 |
$37,296 |
I/I |
(2,400) |
351,378 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,907 |
725,951 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-02-16 |
4 |
AS |
$15.57 |
$37,368 |
I/I |
(2,400) |
348,978 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-03-16 |
4 |
AS |
$18.54 |
$200,232 |
I/I |
(10,800) |
518,178 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-03-17 |
4 |
AS |
$18.50 |
$396,576 |
I/I |
(20,000) |
498,178 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-03-27 |
4 |
AS |
$20.34 |
$252,216 |
I/I |
(12,400) |
485,778 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-03-28 |
4 |
AS |
$18.99 |
$68,728 |
I/I |
(3,600) |
482,178 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-04-10 |
4 |
AS |
$17.08 |
$51,240 |
I/I |
(3,000) |
479,178 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-04-11 |
4 |
AS |
$16.99 |
$71,358 |
I/I |
(4,200) |
474,978 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-04-25 |
4 |
AS |
$17.07 |
$62,397 |
I/I |
(3,600) |
471,378 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-04-26 |
4 |
AS |
$17.78 |
$64,008 |
I/I |
(3,600) |
467,778 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
731,859 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-05-17 |
4 |
AS |
$14.88 |
$35,712 |
I/I |
(2,400) |
465,378 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-05-18 |
4 |
AS |
$14.94 |
$35,856 |
I/I |
(2,400) |
462,978 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-05-30 |
4 |
AS |
$13.44 |
$46,368 |
I/I |
(3,450) |
459,528 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
|
2017-05-31 |
4 |
AS |
$13.26 |
$45,747 |
I/I |
(3,450) |
456,078 |
0 |
- |
|
209 Records found
|
|
Page 4 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|